Compound Ammonium + Glycyrrhetate and Sodium Chloride Injection Hepatic Disease

Product Details
Customization: Available
Production Line: GMP Approved
Transport Package: Carton
Still deciding? Get samples of US$ 1/Piece
Request Sample
Gold Member Since 2018

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Management System Certification
ISO 9001, ISO 14001, GMP
  • Compound Ammonium + Glycyrrhetate and Sodium Chloride Injection Hepatic Disease
  • Compound Ammonium + Glycyrrhetate and Sodium Chloride Injection Hepatic Disease
  • Compound Ammonium + Glycyrrhetate and Sodium Chloride Injection Hepatic Disease
  • Compound Ammonium + Glycyrrhetate and Sodium Chloride Injection Hepatic Disease
  • Compound Ammonium + Glycyrrhetate and Sodium Chloride Injection Hepatic Disease
  • Compound Ammonium + Glycyrrhetate and Sodium Chloride Injection Hepatic Disease
Find Similar Products

Basic Info.

Model NO.
100ml glass bottle
Specification
100ml*80
Trademark
SHIMEN
Origin
Hebei
HS Code
3004909099
Production Capacity
1000000

Product Description

Compound Ammonium + Glycyrrhetate and Sodium Chloride Injection
Product Name: Compound Ammonium + Glycyr rhetate and Sodium Chloride Injection
Indication: It is used for the treatment of acute and chronic hepatic disfunction led by hepatitis and toxic hepatitis. Also used for food poisoning, drug poisoning, and drug allergy. 

Shijiazhuang No. 4 Pharmaceutical Co., Ltd., as one of the leading manufacturers in Chinese pharmaceutical industry and a well-known brand, has a business history of seventy years. The company principally specializes in R & D, manufacture and sales of wide types of drugs mainly including intravenous infusion.
The production lines have achieved full automation control and information control in the production process and logistics process and reached international advanced level by integrating the world's leading equipment and technology.
With product quality as its life, the Company always organizes production in strict accordance with GMP requirements, establishes and implements superior service concepts and measures and provides guarantee for the health of the majority of patients at home and abroad with excellent quality products and services.
The Company has a powerful R&D team and made a number of achievements in scientific research and undertaken many major scientific and technological innovation projects and industrialization projects by firmly grasping the pulse of pharmaceutical development, increasing new product development investment and accelerating the pace of technological innovation.
Large volume injection is the key products, tablets, capsules, small volume injection and other forms are manufactured also. Recently API has been put into production and sales. There are more than ten international advanced production lines for the large volume injection, its production scale, technology level, brand influence and economic benefit are on the forefront of domestic counterparts, and it has become one of China's top 100 pharmaceutical industry enterprises and China's top 10 chemical and pharmaceutical industry preparation export-oriented excellent enterprise brands for many consecutive years.
The products are radiated to all provinces, autonomous regions and municipalities in China and also exported to many overseas markets, including more than 80 countries in Asia, Americas, Europe, Oceania, Africa and other continents, and it has become one of the main export enterprises of infusion products.
Compound Ammonium + Glycyrrhetate and Sodium Chloride Injection Hepatic Disease
Compound Ammonium + Glycyrrhetate and Sodium Chloride Injection Hepatic Disease
Compound Ammonium + Glycyrrhetate and Sodium Chloride Injection Hepatic Disease


 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier